New types of vaccines are currently emerging, and vaccinations are being administered at a hitherto-unprecedented speed. However, greater readiness will be essential, given the risk of new pandemics and bioterrorism. It is said that using nucleic acid platforms to create mock-up vaccines in advance would enable the optimal vaccine to be produced swiftly by introducing into them a modularized antigen tailored to the pathogen concerned.